Specifically, TLR agonists such as those targeting TLR7/8 have shown promise in enhancing the immunogenicity of vaccines against severe diseases like cancer, AIDS, and malaria by linking innate with adaptive immune responses [10]. The gene discussed is TLR7; the disease is malaria.